IDEXX Laboratories
IDXX
S$690.25
Share price
-1.23%
Change (1 day)
5.65%
Change (1 year)
Categories
IDEXX Laboratories (IDXX) - Total debt
Total debt on the balance sheet as of March 2025 : S$1.35 Billion
According to IDEXX Laboratories's latest financial reports the company's total debt is S$1.35 Billion. A company’s total debt is the sum of all current and non-current debts.
IDEXX Laboratories - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | S$1.34 B | -4.83% |
| 2023-12-31 | S$1.40 B | -28.47% |
| 2022-12-31 | S$1.97 B | 41.39% |
| 2021-12-31 | S$1.39 B | 5.02% |
| 2020-12-31 | S$1.32 B | -8.03% |
| 2019-12-31 | S$1.44 B | 5.6% |
| 2018-12-31 | S$1.36 B | -18.98% |
| 2017-12-31 | S$1.68 B | -3.21% |
| 2016-12-31 | S$1.74 B | 5.29% |
| 2015-12-31 | S$1.65 B | 39.33% |
| 2014-12-31 | S$1.18 B | 118.86% |
| 2013-12-31 | S$0.54 B | 106.92% |
| 2012-12-31 | S$0.26 B | -17.8% |
| 2011-12-31 | S$0.31 B | 85.88% |
| 2010-12-31 | S$0.17 B | -1.29% |
| 2009-12-31 | S$0.17 B | -22.28% |
| 2008-12-31 | S$0.22 B | 97.64% |
| 2007-12-31 | S$0.11 B | 936.34% |
| 2006-12-31 | S$10.92 M | 1090.9% |
| 2005-12-31 | S$0.91 M | -68.93% |
| 2004-12-31 | S$2.95 M | 35.78% |
| 2003-12-31 | S$2.17 M | 23% |
| 2002-12-31 | S$1.76 M | -88.6% |
| 2001-12-31 | S$15.51 M | 5.65% |
| 2000-12-31 | S$14.68 M | 148.91% |
| 1999-12-31 | S$5.89 M | -61.99% |
| 1998-12-31 | S$15.51 M | 124.51% |
| 1997-12-31 | S$6.91 M | 64.64% |
| 1996-12-31 | S$4.19 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Neogen NEOG | S$1.14 B | -15.69% | 🇺🇸 USA |
 Petco WOOF | S$3.74 B | 176.06% | 🇺🇸 USA |
 Heska Corporation
HSKA | S$0.14 B | -89.67% | 🇺🇸 USA |
 Henry Schein
HSIC | S$4.12 B | 204.33% | 🇺🇸 USA |
 Abbott Laboratories ABT | S$16.96 B | 1,150.00% | 🇺🇸 USA |
 Meridian Bioscience VIVO | S$39.65 M | -97.08% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | S$43.79 B | 3,127.33% | 🇺🇸 USA |